journal
https://read.qxmd.com/read/38282196/dupilumab-improves-clinical-and-histologic-features-of-eosinophilic-esophagitis-prior-to-12%C3%A2-weeks-of-treatment
#21
LETTER
Twan Sia, Amanda Miller, Leeon Bacchus, Jennie Young, Aditya P Narayan, Rachel Solecki, Jerry Fu, Yuting Jiang, Raisa Khuda, Stanley Liu, Kathleen Love, Shibani Mallik, Amina Sara Matmatte, Paige McDonald, Tanvi Telukunta, Alyssa Roby, Saad Shami, Michelle Zheng, Madison Headen, John Leung
No abstract text is available yet for this article.
January 2024: Clinical and Translational Allergy
https://read.qxmd.com/read/38282195/characteristics-of-mucin-hypersecretion-in-different-inflammatory-patterns-based-on-endotypes-of-chronic-rhinosinusitis
#22
REVIEW
Zhaoxue Zhai, Liting Shao, Zhaoyang Lu, Yujuan Yang, Jianwei Wang, Zhen Liu, Huikang Wang, Yang Zheng, Haoran Lu, Xicheng Song, Yu Zhang
BACKGROUND: Chronic rhinosinusitis (CRS) is usually accompanied by mucin hypersecretion that can lead to mucus accumulation and impair nasal mucociliary clearance, thus exacerbating airway inflammation. Abnormal mucin hypersecretion is regulated by different T helper (Th) cytokines, which are associated with different endotype-driven inflammatory responses. Therefore, it is of great significance to understand how these factors regulate mucin hypersecretion to provide precise treatment strategies for different endotypes of CRS...
January 2024: Clinical and Translational Allergy
https://read.qxmd.com/read/38282194/chronic-spontaneous-urticaria-evidence-of-systemic-microcirculatory-changes
#23
JOURNAL ARTICLE
Yora Mostmans, Marcus Maurer, Bertrand Richert, Vanessa Smith, Karin Melsens, Viviane De Maertelaer, Ines Saidi, Francis Corazza, Olivier Michel
BACKGROUND: Chronic spontaneous urticaria (CSU) is a chronic inflammatory skin disease where activation of endothelial cells (ECs) at sites of skin lesions leads to increased blood flow, leakage of fluid into the skin, cellular infiltration, and vascular remodeling. To understand the disease duration and the sometimes vague systemic symptoms accompanying flares, the objective of this study was to examine if CSU comes with systemic vascular changes at the microcirculatory level. METHODS: We investigated CSU patients (n = 49) and healthy controls (HCs, n = 44) for microcirculatory differences by nailfold videocapillaroscopy (NVC) and for blood levels of the soluble EC biomarkers serum vascular endothelial growth factor (VEGF), soluble E-selectin, and stem cell factor (SCF)...
January 2024: Clinical and Translational Allergy
https://read.qxmd.com/read/38282193/exploring-the-role-of-information-and-communication-technologies-in-allergic-rhinitis-in-specialist-centers-patient-perspectives-on-usefulness-value-and-impact-on-healthcare
#24
JOURNAL ARTICLE
Ivan Cherrez-Ojeda, Jean Bousquet, Zouina Sarfraz, Azza Sarfraz, Monica Rodriguez Gonzales, Anna Bedbrook, Nelson Rosario, Benjamin Zepeda-Ortega, Guillermo Guidos, Ulbio Alcivar Molina, Miguel Felix, Emanuel Vanegas, Karla Robles-Velasco, Luc J Zimmermann, Antonio W D Gavilanes
INTRODUCTION: Information and communication technologies (ICTs) improve patient-centered care and are routinely used in Allergic Rhinitis (AR), but patients' preferences and attitudes are unexplored. This study examines AR-related information preferences and ICT use by AR patients. METHODS: A survey-based cross-sectional study was carried out in Ecuador from July to September 2019 in seven centers of reference for allergic disease. Participants were 18 years or older, diagnosed with AR and had access to ICT and the Internet...
January 2024: Clinical and Translational Allergy
https://read.qxmd.com/read/38282192/exploratory-immunogenicity-outcomes-of-peanut-oral-immunotherapy-findings-from-the-palisade-trial
#25
JOURNAL ARTICLE
Caroline Nilsson, Andrea Vereda, Magnus P Borres, Mats Andersson, Eva Södergren, Magnus Rudengren, Alex Smith, Reyna J Simon, Robert Ryan, Montserrat Fernández-Rivas, Daniel Adelman, Brian P Vickery
BACKGROUND: Immunoglobulin E (IgE) and immunoglobulin G4 (IgG4) to peanut and its components may influence the clinical reactivity to peanut. Allergen-specific immunotherapy is known for modifying both IgE and IgG4. Peanut oral immunotherapy may influence these serological parameters. METHODS: Exploratory analyses of serological data from participants receiving peanut (Arachis hypogaea) allergen powder-dnfp (PTAH) and placebo in the double-blind, randomized, phase 3 PALISADE trial were conducted to evaluate potential relationships between peanut-specific and peanut component-specific (Ara h 1, Ara h 2, Ara h 3, Ara h 6, Ara h 8, and Ara h 9) IgE and IgG4 levels and clinical outcomes...
January 2024: Clinical and Translational Allergy
https://read.qxmd.com/read/38282191/clinical-characteristics-of-allergic-bronchopulmonary-mycosis-caused-by-schizophyllum-commune
#26
JOURNAL ARTICLE
Tsuyoshi Oguma, Takashi Ishiguro, Katsuhiko Kamei, Jun Tanaka, Junko Suzuki, Akira Hebisawa, Yasushi Obase, Hiroshi Mukae, Takae Tanosaki, Shiho Furusho, Koji Kurokawa, Kentaro Watai, Hiroto Matsuse, Norihiro Harada, Ai Nakamura, Takuo Shibayama, Rie Baba, Kentaro Fukunaga, Hisako Matsumoto, Hisano Ohba, Susumu Sakamoto, Shinko Suzuki, Shintetsu Tanaka, Takahiro Yamada, Akira Yamasaki, Yuma Fukutomi, Yoshiki Shiraishi, Takahito Toyotome, Koichi Fukunaga, Terufumi Shimoda, Satoshi Konno, Masami Taniguchi, Katsuyoshi Tomomatsu, Naoki Okada, Koichiro Asano
BACKGROUND: Allergic bronchopulmonary mycosis (ABPM) is an allergic disease caused by type I and type III hypersensitivity to environmental fungi. Schizophyllum commune, a basidiomycete fungus, is one of the most common fungi that causes non-Aspergillus ABPM. OBJECTIVE: Herein, we attempted to clarify the clinical characteristics of ABPM caused by S. commune (ABPM-Sc) compared with those of allergic bronchopulmonary aspergillosis (ABPA). METHODS: Patients with ABPM-Sc or ABPA were recruited from a nationwide survey in Japan, a multicenter cohort, and a fungal database at the Medical Mycology Research Center of Chiba University...
January 2024: Clinical and Translational Allergy
https://read.qxmd.com/read/38282190/cruse-%C3%A2-an-innovative-mobile-application-for-patient-monitoring-and-management-in-chronic-spontaneous-urticaria
#27
JOURNAL ARTICLE
Sophia Neisinger, Bernardo Sousa Pinto, Aiste Ramanauskaite, Jean Bousquet, Karsten Weller, Martin Metz, Markus Magerl, Emek Kocatürk, Ivan Cherrez-Ojeda, Ana M Gimenez-Arnau, Claudio Alberto S Parisi, Sabine Altrichter, Luis Felipe Ensina, Laurence Bouillet, Riccardo Asero, Margarida Gonçalo, Carole Guillet, Krzysztof Rutkowski, Jonathan A Bernstein, Hannah Hardin, Kiran Godse, Zenon Brzoza, Jose Ignacio Larco Sousa, Simon Francis Thomsen, Martijn van Doorn, Michihiro Hide, Young-Min Ye, Staffan Vandersee, Lāsma Lapiņa, Jonny Peter, Zuotao Zhao, Lianyi Han, Iman Nasr, Heike Rockmann-Helmbach, Jennifer Astrup Sørensen, Rabia Öztaş Kara, Natalja Kurjāne, Andrii I Kurchenko, Igor Kaidashev, Vladyslav Tsaryk, Roman Stepanenko, Marcus Maurer
BACKGROUND: Chronic spontaneous urticaria (CSU) is unpredictable and can severely impair patients' quality of life. Patients with CSU need a convenient, user-friendly platform to complete patient-reported outcome measures (PROMs) on their mobile devices. CRUSE® , the Chronic Urticaria Self Evaluation app, aims to address this unmet need. METHODS: CRUSE® was developed by an international steering committee of urticaria specialists. Priorities for the app based on recent findings in CSU were defined to allow patients to track and record their symptoms and medication use over time and send photographs...
January 2024: Clinical and Translational Allergy
https://read.qxmd.com/read/38146806/the-efficacy-and-safety-of-oral-microecological-agents-as-add-on-therapy-for-atopic-dermatitis-a-systematic-review-and-meta-analysis-of-randomized-clinical-trials
#28
REVIEW
Peiwen Xue, Haiyan Qin, Di Qin, Huilin Liu, Juan Li, Rongjiang Jin, Xianjun Xiao
BACKGROUND: Atopic dermatitis (AD) is a common skin disease that is hard to completely cure in a short time. Guidelines recommend the use of topical corticosteroids (TCS) as first-line anti-inflammatory therapy for AD, but long-term use has significant side effects. Microecological agents (MA), including probiotics, prebiotics and synbiotics, have been widely reported as a potential adjunctive therapy of AD, but whether MA can contribute to AD treatment is currently controversial. Therefore, we conducted a systematic review and meta-analysis to investigate whether MA as an add-on therapy for AD has synergistic and attenuated effects and to further understand the role of MA in clinical interventions for AD...
December 2023: Clinical and Translational Allergy
https://read.qxmd.com/read/38146805/cognitive-neuropsychiatric-and-neurological-alterations-in-mastocytosis-a-systematic-review
#29
REVIEW
Elena Sagües-Sesé, Natalia García-Casares, Ivan Álvarez-Twose
BACKGROUND: Mastocytosis manifests with multisystemic symptoms, often involving the nervous system. Numerous cognitive, neuropsychiatric and neurological alterations have been reported in multiple observational studies. METHODS: We performed a qualitative systematic literature review of reported data consulting the electronic databases Medline, Scopus, Web of Science, Cochrane, and BASE until June 2023. RESULTS: We selected 24 studies in which the majority showed that a high proportion of mastocytosis patients suffer cognitive, neuropsychiatric and neurological alterations...
December 2023: Clinical and Translational Allergy
https://read.qxmd.com/read/38146804/sensitization-to-alpha-gal-as-a-cause-of-idiopathic-anaphylaxis
#30
LETTER
Thushali Ranasinghe, Inoka Sepali Aberathna, Jeewantha Jayamali, Thashmi Nimasha, Harshani Chathurangika, Deneshan Peranantharajah, Hashini Colambage, Gathsaurie Neelika Malavige, Chandima Jeewandara
No abstract text is available yet for this article.
December 2023: Clinical and Translational Allergy
https://read.qxmd.com/read/38146803/clinical-relevance-of-pre-and-coseasonal-sublingual-immunotherapy-with-a-300-index-of-reactivity-5-grass-slit-tablet-in-allergic-rhinoconjunctivitis
#31
JOURNAL ARTICLE
Oliver Pfaar, Ulrich Wahn, Giorgio Walter Canonica, Farah Bahbah, Philippe Devillier
BACKGROUND: There is considerable interest in improving the scoring methods for evaluating the efficacy of allergen immunotherapy (AIT) and to show if this is associated with clinically meaningful results from the patient's perspective. We aimed to assess the efficacy and clinical relevance of a 300 index of reactivity (IR) 5-grass pollen sublingual immunotherapy (SLIT) tablet in children, adolescents and adults with moderate to severe grass-induced allergic rhinoconjunctivitis (ARC) with or without controlled asthma using the combined symptom and medication score CSMS0-36 ...
December 2023: Clinical and Translational Allergy
https://read.qxmd.com/read/38146802/food-allergy-what-are-people-looking-for-an-infodemiology-study
#32
LETTER
Karla Robles-Velasco, Matias Panchana-Lascano, Flavio Veintemilla-Burgos, Romina Hinostroza, Jonathan A Bernstein, Ivan Cherrez-Ojeda
No abstract text is available yet for this article.
December 2023: Clinical and Translational Allergy
https://read.qxmd.com/read/38146801/tolerance-to-heated-egg-in-egg-allergy-explanations-and-implications-for-prevention-and-treatment
#33
REVIEW
Audrey Leau, Sandra Denery-Papini, Marie Bodinier, Wieneke Dijk
Hen's egg allergy is the second most frequent food allergy found in children. Allergic symptoms can be caused by raw or heated egg, but a majority of egg-allergic children can tolerate hard-boiled or baked egg. Understanding the reasons for the tolerance towards heated egg provides clues about the molecular mechanisms involved in egg allergy, and the differential allergenicity of heated and baked egg might be exploited to prevent or treat egg allergy. In this review, we therefore discuss (i) why some patients are able to tolerate heated egg; by highlighting the structural changes of egg white (EW) proteins upon heating and their impact on immunoreactivity, as well as patient characteristics, and (ii) to what extent heated or baked EW might be useful for primary prevention strategies or oral immunotherapy...
December 2023: Clinical and Translational Allergy
https://read.qxmd.com/read/38146800/adrenaline-auto-injectors-pharmacokinetic-pharmacodynamic-studies-and-potential-consequences-for-clinical-practice
#34
REVIEW
Margitta Worm, Adam T Fox, Magnus Wickman, Johannes Ring, Motohiro Ebisawa, Guillaume Pouessel, Pete Smith
BACKGROUND: Anaphylaxis is a sudden multisystem allergic reaction which may result in a fatal outcome if not treated promptly. Guidelines worldwide suggest intramuscular adrenaline as the first-line treatment for anaphylaxis outside a perioperative reaction. Adrenaline autoinjectors (AAIs) are widely used self-administrable devices, especially in community settings. Different commercial AAIs have been authorized to be marketed in Europe. For an AAI to be efficacious, a rapid adrenaline delivery in patients, including those who are overweight or obese, resulting in an optimal cardiovascular (CV) response, is a key feature...
December 2023: Clinical and Translational Allergy
https://read.qxmd.com/read/38146799/comparative-analysis-of-cysteine-proteases-reveals-gene-family-evolution-of-the-group-1-allergens-in-astigmatic-mites
#35
JOURNAL ARTICLE
Ling Shi, Qing Xiong, Fu Kiu Ao, Tsz Yau Wan, Xiaojun Xiao, Xiaoyu Liu, Baoqing Sun, Anchalee Tungtrongchitr, Ting Fan Leung, Stephen Kwok Wing Tsui
BACKGROUND: Astigmatic mites contain potent allergens that can trigger IgE-mediated immune responses, leading to allergic diseases such as asthma, allergic rhinitis and atopic dermatitis. In house dust mites Dermatophagoides pteronyssinus and Dermatophagoides farinae, group 1 allergens (Der p 1 and Der f 1), characterized as papain-like cysteine proteases, have been defined as the major allergens that have high prevalence and potency. Previous studies of mite group 1 allergens mainly focused on identification, comparison of sequence and structure, as well as the investigation of cross-reactivity...
December 2023: Clinical and Translational Allergy
https://read.qxmd.com/read/38006387/a-robust-mrna-signature-obtained-via-recursive-ensemble-feature-selection-predicts-the-responsiveness-of-omalizumab-in-moderate-to-severe-asthma
#36
JOURNAL ARTICLE
Sarah Kidwai, Pietro Barbiero, Irma Meijerman, Alberto Tonda, Paula Perez-Pardo, Pietro Lio, Anke H van der Maitland-Zee, Daniel L Oberski, Aletta D Kraneveld, Alejandro Lopez-Rincon
BACKGROUND: Not being well controlled by therapy with inhaled corticosteroids and long-acting β2 agonist bronchodilators is a major concern for severe-asthma patients. The current treatment option for these patients is the use of biologicals such as anti-IgE treatment, omalizumab, as an add-on therapy. Despite the accepted use of omalizumab, patients do not always benefit from it. Therefore, there is a need to identify reliable biomarkers as predictors of omalizumab response. METHODS: Two novel computational algorithms, machine-learning based Recursive Ensemble Feature Selection (REFS) and rule-based algorithm Logic Explainable Networks (LEN), were used on open accessible mRNA expression data from moderate-to-severe asthma patients to identify genes as predictors of omalizumab response...
November 2023: Clinical and Translational Allergy
https://read.qxmd.com/read/38006386/application-of-a-dried-blood-spot-based-proteomic-and-genetic-assay-for-diagnosing-hereditary-angioedema
#37
JOURNAL ARTICLE
Marius-Ionuţ Iuraşcu, Zsuzsanna Balla, Catarina Pereira, Noémi Andrási, Lilian Varga, Dorottya Csuka, Ágnes Szilágyi, Kornelia Tripolszki, Suliman Khan, Iuliana Susnea, Peter Bauer, Claudia Cozma, Henriette Farkas
BACKGROUND: Hereditary angioedema (HAE) with C1-inhibitor deficiency (C1-INH-HAE) is a rare disease caused by low level (type I) or dysfunction (type II) of the C1-inhibitor protein with subsequent reduction of certain complement protein levels. METHODS: To develop and test the reliability of a two-tier method based on C1-INH and C4 quantitation followed by genetic analysis from dried blood spot (DBS) for establishing the diagnosis of C1-INH-HAE. C1-INH and C4 proteins have been quantified in human plasma using a classical immuno-assay and in DBS using a newly developed proteolytic liquid chromatography-mass spectrometry method...
November 2023: Clinical and Translational Allergy
https://read.qxmd.com/read/38006385/peanut-allergen-ara-h-6-is-detectable-in-blood-transfusion-products
#38
LETTER
Fleur A C Jansen, Klaske van Norren, Joseph L Baumert, Annegeet van den Bos, Joannes F M Jacobs, Stef J Koppelman
No abstract text is available yet for this article.
November 2023: Clinical and Translational Allergy
https://read.qxmd.com/read/38006384/inflammatory-related-plasma-proteins-involved-in-acute-preschool-wheeze
#39
JOURNAL ARTICLE
Idun Holmdahl, Sandip Chakraborty, Angela Hoyer, Anastasia Filiou, Anna Asarnoj, Anders Sjölander, Magnus P Borres, Marianne van Hage, Gunilla Hedlin, Jon R Konradsen, Cilla Söderhäll
BACKGROUND: Preschool wheeze is a risk factor for asthma development. However, the molecular mechanism behind a wheezing episode is not well understood. OBJECTIVE: Our aims were to assess the association of plasma proteins with acute preschool wheeze and to study the proteins with differential expression at the acute phase at revisit after 3 months. Additionally, to investigate the relationship between protein expression and clinical parameters. METHOD: We measured 92 inflammatory proteins in plasma and clinical parameters from 145 children during an episode of preschool wheeze (PW) and at the revisit after 3 months (PW-R, n = 113/145) and 101 healthy controls (HC) aged 6-48 months in the GEWAC cohort using the antibody-mediated proximity extension-based assay (Olink Proteomics, Uppsala)...
November 2023: Clinical and Translational Allergy
https://read.qxmd.com/read/38006383/human-bocavirus-1-coinfection-is-associated-with-decreased-cytokine-expression-in-the-rhinovirus-induced-first-wheezing-episode-in-children
#40
JOURNAL ARTICLE
Pekka Hurme, Reetta Sahla, Beate Rückert, Tero Vahlberg, Riitta Turunen, Tytti Vuorinen, Mübeccel Akdis, Maria Söderlund-Venermo, Cezmi Akdis, Tuomas Jartti
BACKGROUND: Rhinovirus (RV)-induced first wheezing episodes in children are associated with a markedly increased risk of asthma. Previous studies have suggested that human bocavirus 1 (HBoV1) may modify RV-induced immune responses in young children. We investigated cytokine profiles of sole RV- and dual RV-HBoV1-induced first wheezing episodes, and their association with severity and prognosis. METHODS: Fifty-two children infected with only RV and nine children infected with dual RV-HBoV1, aged 3-23 months, with severe first wheezing episodes were recruited...
November 2023: Clinical and Translational Allergy
journal
journal
43899
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.